Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Eli Lilly Q3 Adj. EPS $7.02 Beats $5.70 Estimate, Sales $17.601B Beat $16.016B Estimate

Author: Benzinga Newsdesk | October 30, 2025 05:46am
Eli Lilly (NYSE:LLY) reported quarterly earnings of $7.02 per share which beat the analyst consensus estimate of $5.70 by 23.27 percent. This is a 494.92 percent increase over earnings of $1.18 per share from the same period last year. The company reported quarterly sales of $17.601 billion which beat the analyst consensus estimate of $16.016 billion by 9.90 percent. This is a 53.87 percent increase over sales of $11.439 billion the same period last year.

Posted In: LLY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist